CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 153 filers reported holding CONMED CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,503,000 | +27.9% | 18,070 | -1.2% | 0.05% | +41.7% |
| Q4 2018 | $1,175,000 | -18.9% | 18,295 | +0.1% | 0.04% | +2.9% |
| Q3 2018 | $1,448,000 | -17.4% | 18,280 | -56.3% | 0.04% | +59.1% |
| Q1 2016 | $1,754,000 | -4.5% | 41,837 | +0.3% | 0.02% | +10.0% |
| Q4 2015 | $1,837,000 | -9.9% | 41,707 | -2.4% | 0.02% | -9.1% |
| Q3 2015 | $2,039,000 | -19.2% | 42,717 | -1.4% | 0.02% | 0.0% |
| Q2 2015 | $2,524,000 | -45.1% | 43,327 | -52.4% | 0.02% | -38.9% |
| Q1 2015 | $4,594,000 | +90.8% | 91,000 | +69.9% | 0.04% | +100.0% |
| Q4 2014 | $2,408,000 | +13.3% | 53,560 | -7.2% | 0.02% | +20.0% |
| Q3 2014 | $2,125,000 | +18.6% | 57,685 | +42.1% | 0.02% | +25.0% |
| Q2 2014 | $1,791,000 | +4.4% | 40,585 | +2.8% | 0.01% | 0.0% |
| Q1 2014 | $1,715,000 | -15.6% | 39,480 | -17.4% | 0.01% | -20.0% |
| Q4 2013 | $2,031,000 | +27.6% | 47,810 | +1.9% | 0.02% | +15.4% |
| Q3 2013 | $1,592,000 | +15.2% | 46,900 | +6.0% | 0.01% | +8.3% |
| Q2 2013 | $1,382,000 | – | 44,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |